Malignant Ascites

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-06-03
Clinical Trial Update: A Study of Bevacizumab to Prevent Malignant Ascites [Phase 2]
This document reports the withdrawal of a Phase 2 trial evaluating bevacizumab to prevent malignant ascites.